MCID: ATR011
MIFTS: 62

Atrial Fibrillation malady

Genetic diseases, Rare diseases categories

Aliases & Classifications for Atrial Fibrillation

About this section

Aliases & Descriptions for Atrial Fibrillation:

Name: Atrial Fibrillation 8 44 32 61
 
a-Fib 8


Classifications:



External Ids:

Disease Ontology8 DOID:0060224
MeSH33 D001281
ICD9CM27 427.31

Summaries for Atrial Fibrillation

About this section
MedlinePlus:32 An arrhythmia is a problem with the speed or rhythm of the heartbeat. atrial fibrillation (af) is the most common type of arrhythmia. the cause is a disorder in the heart's electrical system. often, people who have af may not even feel symptoms. but you may feel palpitations -- an abnormal rapid heartbeat shortness of breath weakness or difficulty exercising chest pain dizziness or fainting fatigue confusion af can lead to an increased risk of stroke. in many patients, it can also cause chest pain, heart attack, or heart failure. doctors diagnose af using family and medical history, a physical exam, and a test called an electrocardiogram (ekg), which looks at the electrical waves your heart makes. treatments include medicines and procedures to restore normal rhythm. nih: national heart, lung, and blood institute

MalaCards based summary: Atrial Fibrillation, also known as a-fib, is related to mitral valve disease and familial atrial fibrillation. An important gene associated with Atrial Fibrillation is KCNQ1 (potassium voltage-gated channel, KQT-like subfamily, member 1), and among its related pathways are Cardiomyocyte Differentiation through BMP Receptors and Salivary secretion. The drugs atenolol and deslanoside and the compounds clofilium and chromanol have been mentioned in the context of this disorder. Affiliated tissues include heart, brain and lung, and related mouse phenotypes are normal and nervous system.

Disease Ontology:8 A heart conduction disease that is characterized by uncoordinated electrical activity in the heart's upper chambers (the atria), which causes the heartbeat to become fast and irregular and has symptoms palpitations, weakness, fatigue, lightheadedness, dizziness, confusion, shortness of breath and chest pain.

Wikipedia:64 Atrial fibrillation (AF or A-fib) is an abnormal heart rhythm characterized by rapid and irregular... more...

Related Diseases for Atrial Fibrillation

About this section

Diseases in the Atrial Fibrillation family:

Atrial Fibrillation, Familial, 6 Atrial Fibrillation, Familial, 11
Atrial Fibrillation, Familial, 10 Atrial Fibrillation, Familial, 5
Atrial Fibrillation, Familial, 2 Atrial Fibrillation, Familial, 1
Atrial Fibrillation, Familial, 3 Atrial Fibrillation, Familial, 14
Atrial Fibrillation, Familial, 7 Atrial Fibrillation, Familial, 12
Atrial Fibrillation, Familial, 8 Atrial Fibrillation, Familial, 9
Atrial Fibrillation, Familial, 13 Atrial Fibrillation, Familial, 4
Atrial Fibrillation 15 Familial Atrial Fibrillation
Kcne2-Related Familial Atrial Fibrillation Kcnq1-Related Familial Atrial Fibrillation
Kcna5-Related Familial Atrial Fibrillation Kcnj2-Related Familial Atrial Fibrillation
Abcc9-Related Familial Atrial Fibrillation Gja5-Related Familial Atrial Fibrillation

Diseases related to Atrial Fibrillation via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 249)
idRelated DiseaseScoreTop Affiliating Genes
1mitral valve disease32.2NPPA
2familial atrial fibrillation32.0SCN5A, KCNQ1, KCNE2
3sick sinus syndrome31.7NPPA, SCN5A, HCN4
4congestive heart failure31.4NPPB, NPPA, AGT
5atrioventricular block31.3SCN5A, NPPB
6acute myocardial infarction31.1AGT, NPPA, NPPB
7central sleep apnea31.0NPPB
8hypertensive heart disease31.0NPPB, NPPA
9coronary artery disease30.9NPPA, NPPB, AGT
10short qt syndrome 230.9KCNQ1
11dilated cardiomyopathy30.9ABCC9, NPPA, NPPB, SCN5A
12mitral valve stenosis30.8NPPA, NPPB
13cor pulmonale30.8NPPB, NPPA
14sick sinus syndrome 230.8HCN4
15brugada syndrome30.8SCN2B, HCN4, SCN1B, SCN5A, KCNE2, KCNE1
16long qt syndrome30.7KCNE1, KCNQ1, SCN5A, KCNJ2, KCNA5, KCNE2
17pulmonary hypertension30.2NPPA, NPPB
18wolff-parkinson-white syndrome10.9
19pulmonary vein stenosis10.9
20atrial fibrillation and stroke10.9
21myocardial infarction10.8
22endotheliitis10.7
23hypertrophic cardiomyopathy10.7
24hyperthyroidism10.7
25systolic heart failure10.6
26cor triatriatum10.6
27atherosclerosis10.6
28sleep apnea10.6
29cerebritis10.6
30long qt syndrome 110.6KCNQ1
31artery disease10.6
32pericarditis10.5
33vascular disease10.5
34aneurysm10.5
35cor triatriatum sinister10.5
36brugada syndrome 110.5SCN5A
37atrial fibrillation, familial, 610.5
38atrial fibrillation, familial, 1110.5
39atrial fibrillation, familial, 1010.5
40atrial fibrillation, familial, 110.5
41atrial fibrillation, familial, 310.5
42atrial fibrillation, familial, 710.5
43atrial fibrillation, familial, 1210.5
44atrial fibrillation, familial, 910.5
45atrial fibrillation, familial, 410.5
46atrial fibrillation 1510.5
47obstructive sleep apnea10.5
48dextrocardia10.5
49cardiac tamponade10.5
50pericardial effusion10.5

Graphical network of the top 20 diseases related to Atrial Fibrillation:



Diseases related to atrial fibrillation

Symptoms for Atrial Fibrillation

About this section

Drugs & Therapeutics for Atrial Fibrillation

About this section

Genetic Tests for Atrial Fibrillation

About this section

Anatomical Context for Atrial Fibrillation

About this section

MalaCards organs/tissues related to Atrial Fibrillation:

31
Heart, Brain, Lung, Testes, Endothelial, Kidney, Thyroid, Neutrophil, Bone, Liver, Monocytes, Prostate, B cells

Animal Models for Atrial Fibrillation or affiliated genes

About this section

MGI Mouse Phenotypes related to Atrial Fibrillation:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00028739.2HCN4, SCN1B, SCN5A, ZFHX3, GJA5, KCNQ1
2MP:00036318.6KCNA5, KCNE1, KCNQ1, NUP155, SCN1B, SCN2B
3MP:00053698.4KCNQ1, KCNJ2, KCNA5, ABCC9, HCN4, SCN5A
4MP:00053768.3KCNE1, KCNJ2, KCNA5, ABCC9, KCNE2, KCNQ1
5MP:00107688.1ABCC9, KCNJ2, HCN4, NUP155, SCN1B, SCN5A
6MP:00053857.9AGT, ABCC9, KCNA5, KCNJ2, KCNE1, KCNQ1

Publications for Atrial Fibrillation

About this section

Articles related to Atrial Fibrillation:

(show top 50)    (show all 1863)
idTitleAuthorsYear
1
Meta-analysis comparing carvedilol versus metoprolol for the prevention of postoperative atrial fibrillation following coronary artery bypass grafting. (24332247)
2014
2
Circulating Endothelial Cells and Platelet Microparticles in Mitral Valve Disease With and Without Atrial Fibrillation. (25115553)
2014
3
Supraventricular Premature Beats and Short Atrial Runs Predict Atrial Fibrillation in Continuously Monitored Patients With Cryptogenic Stroke. (24425117)
2014
4
Esophageal duplication cyst: a rare cause of atrial fibrillation in a young adult patient. (24942264)
2014
5
Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study. (24297188)
2013
6
Edoxaban versus warfarin in patients with atrial fibrillation. (24251359)
2013
7
Pivotal roles of risk factors for incident atrial fibrillation in patients with newly diagnosed hyperthyroidism. (23610584)
2013
8
Elevated norepinephrine may be an etiological factor in a wide range of diseases: age-related macular degeneration, systemic lupus erythematosus, atrial fibrillation, metabolic syndrome. (23410497)
2013
9
Atrial fibrillation and stroke prevention: is warfarin still an option? Yes: Debate at the Controversies in Neurology Congress, Beijing, October 2011. (23232666)
2013
10
P-Wave Abnormality Predicts Recurrence of Atrial Fibrillation after Electrical Cardioversion: A Prospective Study. (24320565)
2013
11
Ischaemic hepatitis precipitated by recurrent episodes of atrial fibrillation. (24433649)
2013
12
Hemodynamically unstable atrial fibrillation after oral contrast dye instillation in a case of Boerhaave's syndrome. (24348308)
2013
13
Atrial fibrillation as an uncommon presentation in a large pleomorphic xanthoastrocytoma. (22086138)
2012
14
Polymorphisms of the angiotensin-converting enzyme and angiotensinogen gene in patients with atrial fibrillation. (21436211)
2011
15
Gastroesophageal reflux disease: another risk factor for atrial fibrillation? (22261930)
2011
16
Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and atrial fibrillation: a meta-analysis. (21076147)
2011
17
Association between familial atrial fibrillation and risk of new-onset atrial fibrillation. (21076174)
2010
18
Increased expression of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type 2 in human atria during atrial fibrillation. (20063294)
2010
19
MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. (21098446)
2010
20
Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation. (20694273)
2010
21
ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural heart disease: implications for electrical remodeling. (19648063)
2009
22
Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion. (19367026)
2009
23
The use of B-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea. (18619686)
2009
24
Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease. (19117407)
2009
25
Preventive strategy for atrial fibrillation in arterial hypertension]. (20017344)
2009
26
Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure. (18339785)
2008
27
Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation. (18477727)
2008
28
Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. (18294494)
2008
29
Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population. (18496132)
2008
30
Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches. (18515286)
2008
31
Asymmetrical dimethylarginine level in atrial fibrillation. (18372578)
2008
32
New developments in anticoagulation for atrial fibrillation. (18814828)
2008
33
Advancement in antithrombotics for stroke prevention in atrial fibrillation. (18425569)
2008
34
New facts about pathogenesis of atrial fibrillation: correlation between changes in bioelectric brain activity and recurrence of atrial fibrillation paroxysms]. (18038585)
2007
35
Gene mutations, atrial fibrillation, and the elusive cigar. (17185994)
2007
36
Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation. (17556195)
2007
37
The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation. (17118431)
2007
38
Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm. (17498581)
2007
39
Influence of atrial fibrillation on cardiac brain natriuretic peptide release during haemodynamic stress in heart failure. (16309956)
2006
40
A longitudinal population-based study of prothrombotic factors in elderly subjects with atrial fibrillation: the Rotterdam Study 1990-1999. (16824187)
2006
41
Activation of the calcineurin signaling pathway induces atrial hypertrophy during atrial fibrillation. (16389460)
2006
42
Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin? (16410483)
2006
43
Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis? (16179272)
2005
44
Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation. (16038717)
2005
45
Rate versus rhythm control in patients with atrial fibrillation: what the trials really say. (16060699)
2005
46
Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia. (14713509)
2003
47
Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. (10533580)
1999
48
Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: role of duration of atrial fibrillation. (9489971)
1998
49
Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. (1406859)
1992
50
Raised plasma concentrations of atrial natriuretic peptide are independent of left atrial dimensions in patients with chronic atrial fibrillation. (2143916)
1990

Variations for Atrial Fibrillation

About this section

Clinvar genetic disease variations for Atrial Fibrillation:

5
id Gene Variation Type Significance SNP ID Assembly Location
1KCNQ1NM_000218.2(KCNQ1): c.418A> G (p.Ser140Gly)single nucleotide variantPathogenicrs120074192GRCh37Chr 11, 2549189: 2549189
2KCNE2NM_172201.1(KCNE2): c.79C> T (p.Arg27Cys)single nucleotide variantPathogenicrs74315449GRCh37Chr 21, 35742856: 35742856
3KCNQ1NM_000218.2(KCNQ1): c.625T> C (p.Ser209Pro)single nucleotide variantPathogenicrs199472705GRCh37Chr 11, 2592575: 2592575

Expression for genes affiliated with Atrial Fibrillation

About this section
Search GEO for disease gene expression data for Atrial Fibrillation.

Pathways for genes affiliated with Atrial Fibrillation

About this section

Compounds for genes affiliated with Atrial Fibrillation

About this section

Compounds related to Atrial Fibrillation according to GeneCards Suite gene sharing:

(show top 50)    (show all 68)
idCompoundScoreTop Affiliating Genes
1clofilium44 2811.5KCNQ1, KCNA5
2chromanol4410.4KCNE1, KCNQ1
3hncs4410.4NPPA, NPPB
4nicorandil44 2811.4NPPA, ABCC9
5p000354410.4NPPB, NPPA
6alacepril4410.4NPPA, NPPB
7candoxatril44 1111.4NPPA, NPPB
8indapamide44 1111.3KCNQ1, KCNE1
9flecainide50 44 28 1113.3KCNA5, SCN5A
10imidapril44 5011.3NPPB, NPPA
11ly 835834410.3NPPA, AGT
12chromanol 293b60 44 2812.3KCNE1, KCNQ1
13propafenone28 44 50 1113.3SCN5A, KCNA5
14tetrodotoxin citrate6010.2SCN1B, SCN2B, SCN5A
15qx 314 chloride6010.2SCN1B, SCN2B, SCN5A
16phrixotoxin 36010.2SCN1B, SCN2B, SCN5A
17urodilatin4410.2NPPA, NPPB
18glibenclamide44 28 50 6013.2KCNQ1, KCNJ2, ABCC9
19veratridine44 60 2812.2SCN1B, SCN5A, SCN2B
20zonisamide44 50 1112.2SCN2B, SCN5A, SCN1B
21enalaprilat4410.1NPPB, NPPA, AGT
22trandolapril44 1111.1NPPA, NPPB
23lisinopril44 50 24 1113.1NPPA, NPPB, AGT
248-bromo cgmp4410.1AGT, NPPA, NPPB
25perindopril44 50 1112.1NPPA, AGT, NPPB
26amlodipine44 50 24 1113.1NPPA, AGT, NPPB
27enalapril44 50 1112.1AGT, NPPB, NPPA
28bisoprolol44 50 1112.1NPPA, NPPB
29cromakalim44 2811.1KCNQ1, ABCC9
30ica 1103816010.1KCNE1, KCNQ1, KCNE2, KCNA5
31tetrodotoxin44 60 2812.1SCN1B, SCN2B, SCN5A
32shk-dap226010.1KCNA5, KCNE1, KCNE2, KCNQ1
33xe 991 dihydrochloride6010.1KCNQ1, KCNE2, KCNE1, KCNA5
34e-4031 dihydrochloride6010.1KCNQ1, KCNE2, KCNE1, KCNA5
35jnj 3036010.1KCNQ1, KCNE2, KCNE1, KCNA5
36ang ii4410.1NPPB, AGT, NPPA
37captopril44 60 50 28 1114.1AGT, NPPB, NPPA
38l-nmma4410.1AGT, NPPB, NPPA
39hanp4410.1NPPB, NPPA
40moxonidine4410.0NPPB, NPPA
41phenylephrine44 28 24 1113.0NPPB, AGT, NPPA
42losartan44 50 28 1112.9AGT, NPPA, NPPB
43inulin449.9AGT, NPPA
44epinephrine44 24 1111.9AGT, KCNQ1, NPPA, NPPB
45isoproterenol44 1110.8KCNQ1, AGT, NPPB, NPPA, KCNJ2
46fosinopril44 1110.7NPPB, NPPA
47arginine449.2AGT, SCN5A, NPPB, NPPA, KCNJ2, KCNE1
48calcium44 50 24 1112.0NPPB, KCNQ1, KCNA5, KCNJ2, SCN1B, SCN5A
49potassium44 24 1110.5KCNE1, KCNE2, KCNQ1, HCN4, SCN5A, NPPA
50sodium44 249.4SCN5A, KCNE2, NPPA, NPPB, AGT, SCN2B

GO Terms for genes affiliated with Atrial Fibrillation

About this section

Cellular components related to Atrial Fibrillation according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1lysosomeGO:00057649.8KCNQ1, KCNE2, KCNE1
2voltage-gated sodium channel complexGO:00015189.8SCN1B, SCN2B, SCN5A
3T-tubuleGO:00303159.7SCN5A, SCN1B, KCNJ2
4sarcolemmaGO:00423839.6ABCC9, KCNQ1, SCN5A
5intercalated discGO:00147049.5KCNA5, KCNJ2, SCN1B, SCN5A, GJA5
6voltage-gated potassium channel complexGO:00080769.3KCNQ1, KCNE2, KCNE1, KCNJ2, KCNA5, ABCC9

Biological processes related to Atrial Fibrillation according to GeneCards Suite gene sharing:

(show all 37)
idNameGO IDScoreTop Affiliating Genes
1regulation of ventricular cardiac muscle cell membrane depolarizationGO:006037310.4SCN5A, GJA5
2bundle of His cell to Purkinje myocyte communicationGO:008606910.3GJA5, SCN5A
3regulation of delayed rectifier potassium channel activityGO:0190225910.3KCNE1, KCNE2
4regulation of atrial cardiac muscle cell membrane repolarizationGO:006037210.3KCNA5, KCNQ1, SCN5A
5response to pyrethroidGO:004668410.3SCN2B, SCN1B
6membrane repolarizationGO:008600910.3KCNE1, KCNE2
7regulation of membrane repolarizationGO:006030610.3KCNQ1, KCNE2, KCNJ2
8regulation of potassium ion transmembrane transportGO:0190137910.3KCNE1, KCNE2
9potassium ion importGO:001010710.2ABCC9, KCNJ2, KCNE2
10cGMP biosynthetic processGO:000618210.2NPPA, NPPB
11regulation of sodium ion transmembrane transporter activityGO:0200064910.2SCN2B, SCN1B
12receptor guanylyl cyclase signaling pathwayGO:000716810.2NPPB, NPPA
13atrial cardiac muscle cell action potentialGO:008601410.2GJA5, NUP155, KCNQ1, KCNA5
14membrane repolarization during cardiac muscle cell action potentialGO:008601310.1KCNJ2, KCNE1, KCNQ1
15regulation of blood vessel sizeGO:005088010.1NPPA, NPPB
16positive regulation of potassium ion transmembrane transportGO:0190138110.1KCNQ1, KCNJ2, KCNE1
17cellular response to mechanical stimulusGO:007126010.1AGT, KCNJ2, NPPA
18cellular response to cAMPGO:007132010.1KCNE1, HCN4, KCNQ1
19potassium ion exportGO:007143510.0KCNQ1, KCNA5, KCNE1, KCNE2
20regulation of vasoconstrictionGO:001922910.0KCNA5, AGT
21regulation of atrial cardiac muscle cell membrane depolarizationGO:006037110.0GJA5, SCN5A, SCN2B, SCN1B
22potassium ion transportGO:000681310.0ABCC9, KCNA5, GJA5, KCNJ2
23positive regulation of renal sodium excretionGO:003581510.0NPPB, AGT
24regulation of heart rateGO:000202710.0SCN5A, HCN4
25membrane repolarization during action potentialGO:008601110.0KCNE1, KCNE2, KCNJ2, KCNQ1
26cardiac muscle contractionGO:006004810.0SCN1B, SCN2B, SCN5A, KCNQ1
27membrane depolarization during cardiac muscle cell action potentialGO:008601210.0SCN5A, KCNJ2, SCN1B, SCN2B
28positive regulation of sodium ion transportGO:00107659.9SCN1B, SCN5A
29sodium ion transmembrane transportGO:00357259.9HCN4, SCN2B, SCN1B, SCN5A
30ventricular cardiac muscle cell action potentialGO:00860059.9KCNQ1, GJA5, SCN5A, KCNE1, KCNE2
31negative regulation of cell growthGO:00303089.8NPPA, NPPB, AGT
32potassium ion transmembrane transportGO:00718059.7KCNQ1, HCN4, KCNE2, KCNE1, KCNJ2
33membrane depolarizationGO:00518999.7SCN1B, SCN5A
34regulation of ventricular cardiac muscle cell membrane repolarizationGO:00603079.6GJA5, KCNE1, KCNE2, KCNQ1, SCN1B, SCN5A
35cardiac muscle cell action potential involved in contractionGO:00860029.5KCNJ2, KCNE1, KCNE2, SCN1B, SCN5A, SCN2B
36synaptic transmissionGO:00072689.4SCN1B, HCN4, KCNA5, KCNJ2, ABCC9, KCNQ1
37regulation of heart rate by cardiac conductionGO:00860919.0KCNA5, GJA5, KCNJ2, KCNE1, KCNE2, KCNQ1

Molecular functions related to Atrial Fibrillation according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarizationGO:008608910.3KCNQ1, KCNA5
2outward rectifier potassium channel activityGO:001527110.1KCNA5, KCNQ1
3scaffold protein bindingGO:009711010.1KCNA5, KCNQ1, SCN5A
4voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarizationGO:0190228210.1KCNE1, KCNE2, KCNQ1
5voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarizationGO:008600810.1KCNQ1, KCNJ2, KCNE1
6voltage-gated sodium channel activity involved in cardiac muscle cell action potentialGO:008600610.1SCN5A, SCN2B, SCN1B
7sodium channel regulator activityGO:001708010.0SCN2B, SCN1B
8voltage-gated sodium channel activityGO:000524810.0SCN5A, SCN1B, HCN4
9ion channel bindingGO:00443259.9ABCC9, KCNE2, KCNQ1, SCN5A
10delayed rectifier potassium channel activityGO:00052519.9KCNA5, KCNE1, KCNE2, KCNQ1
11potassium channel regulator activityGO:00154599.9ABCC9, KCNE1, KCNE2
12voltage-gated potassium channel activityGO:00052499.8HCN4, KCNQ1, KCNE1
13inward rectifier potassium channel activityGO:00052429.8KCNE2, KCNJ2
14hormone activityGO:00051799.6AGT, NPPB, NPPA

Sources for Atrial Fibrillation

About this section
2CDC
12ExPASy
13FDA
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCI
39NCIt
40NDF-RT
43NINDS
44Novoseek
46OMIM
47OMIM via Orphanet
51PubMed
52QIAGEN
57SNOMED-CT via Orphanet
61UMLS
62UMLS via Orphanet